CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biomerieux SA Company Snapshot
Biomerieux SA operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomerieux SA with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of DENMARK (2020 sales of 17.67 billion Danish Kroner [US$2.77 billion] of which 100% was Pharmaceuticals), Stada Arzneimittel AG of GERMANY (3.01 billion Euros [US$3.50 billion] of which 55% was Generics), and Ipsen SA (2.69 billion Euros [US$3.13 billion] of which 89% was Specialty Care).

Sales Analysis. During the third quarter of 2021, sales at Biomerieux SA totalled 877.40 million Euro. This is an increase of 11.1% from the 789.40 million Euro in sales at the company during the third quarter of 2020. During the first three quarters of 2021, sales totalled 2.45 billion Euro, which is 8.2% higher than through the first three quarters of 2020. During the previous 34 quarters, sales at Biomerieux SA have increased compared with the same quarter in the previous year. Sales at Biomerieux SA appear to have some seasonality: during each of the previous 9 years, sales have been highest during the fourth quarter, which has accounted for between 26.8% and 29.8% of the annual sales. Biomerieux SA reported sales of 3.12 billion Euro (US$3.63 billion) for the year ending December of 2020. This represents an increase of 16.6% versus 2019, when the company's sales were 2.67 billion Euro. Sales at Biomerieux SA have increased during each of the previous five years (and since 2015, sales have increased a total of 59%). Sales of Diagnostic Clinical Equipment saw an increase of 20.6% in 2020, from 2.21 billion Euro to 2.66 billion Euro. Not all segments of Biomerieux SA experienced an increase in sales in 2020: sales of Microbiological Industrial Equipment fell 2.6% to 454.60 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biomerieux SA
  Stock Performance Chart for Biomerieux SA
 
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 104.40
(Figures in Euros )
1 Week 5.2%   13 Weeks -2.7%  
4 Weeks 10.1%   52 Weeks -17.1%  
 
Biomerieux SA Key Data:
  Ticker: BIM Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2020 Sales 3,118,200,000
(Year Ending Jan 2021).
Employees: 12,756
  Currency: Euros Market Cap: 12,329,144,100
  Fiscal Yr Ends: December Shares Outstanding: 118,095,250
  Share Type: Actions Ordinaires Closely Held Shares: 75,889,151
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.